Peptide Blends
CagriSema (10mg+10mg)
CagriSema (10mg+10mg) — research-grade reference material, supplied in multiple sizes.
- Product Code
- CS
- Purity
- 99%
- Form
- Lyophilized powder
- Packaging
- 20mg*10vials
Ships from multiple warehouses — typically 2–5 business days to nearby destinations. International orders coordinated per destination.
No prices are published. Available scope, specifications and documentation are confirmed during specification review. Supplied for research and analytical use by qualified organizations — see our Research Use Only policy.
Specification
- Purity specification
- 99%
- Available sizes
- 20mg × 10vials
- Storage
- 2–8 °C, away from light and moisture
- MOQ
- On request
Research Applications
- A research combination of cagrilintide (amylin analog) and semaglutide (GLP-1 receptor agonist) studied for synergistic weight reduction.
- Dual amylin/GLP-1 receptor activation is investigated for complementary effects on appetite, satiety, and energy balance.
- Research applications include metabolic models evaluating greater body-weight reduction than either monotherapy component.
- Studied for improvements in glycemic control and metabolic parameters in type 2 metabolic research settings.
Cagrilintide + Semaglutide combination, synergistic metabolic-research effect
Related
Related solutions
Send us your specification
Share your sequence, format, packaging and documentation needs. Our team will review scope and next project steps.